Structure of Mpro from COVID-19 virus and discovery of its inhibitors (Q89975279)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 9 April 2020

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Language	Label	Description	Also known as
English	Structure of Mpro from COVID-19 virus and discovery of its inhibitors	scientific article published on 9 April 2020	Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Statements

scholarly article

0 references

Structure of Mpro from COVID-19 virus and discovery of its inhibitors (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

non-structural protein 5 [SARS-CoV-2]

1 reference

based on heuristic

inferred from abstract

structural biology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from abstract

Structure of Mpro from COVID-19 virus and discovery of its inhibitors

0 references

30

object named as

Zihe Rao

0 references

author name string

Zhenming Jin

1

0 references

Xiaoyu Du

2

0 references

Yechun Xu

3

0 references

Yongqiang Deng

4

0 references

Meiqin Liu

5

0 references

Yao Zhao

6

0 references

Bing Zhang

7

0 references

Xiaofeng Li

8

0 references

Leike Zhang

9

0 references

Chao Peng

10

0 references

Yinkai Duan

11

0 references

Jing Yu

12

0 references

Lin Wang

13

0 references

Kailin Yang

14

0 references

Fengjiang Liu

15

0 references

Rendi Jiang

16

0 references

Xinglou Yang

17

0 references

Tian You

18

0 references

Xiaoce Liu

19

0 references

Xiuna Yang

20

0 references

Fang Bai

21

0 references

Hong Liu

22

0 references

Xiang Liu

23

0 references

Luke W. Guddat

24

0 references

Wenqing Xu

25

0 references

Gengfu Xiao

26

0 references

Chengfeng Qin

27

0 references

Zhengli Shi

28

0 references

Hualiang Jiang

29

0 references

Haitao Yang

31

0 references

language of work or name

0 references

publication date

9 April 2020

0 references

full work available at URL

https://www.nature.com/articles/s41586-020-2223-y_reference.pdf

0 references

0 references

A Novel Coronavirus from Patients with Pneumonia in China, 2019

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

A pneumonia outbreak associated with a new coronavirus of probable bat origin

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

A new coronavirus associated with human respiratory disease in China

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

SARS and MERS: recent insights into emerging coronaviruses

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Conservation of substrate specificities among coronavirus main proteases

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Structure of the Main Protease from a Global Infectious Human Coronavirus, HCoV-HKU1

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS)

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Michael Acceptor-Based Peptidomimetic Inhibitor of Main Protease from Porcine Epidemic Diarrhea Virus.

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitor

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

ANTIPHOGISTIC EFFECTS OF ANTISEROTONIN (SQ 10,643) AND AMINOPYRINE IN RATS VERSUS ENDOTOXIN AND OTHER AGENTS

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

A detergent-based assay for the detection of promiscuous inhibitors

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial.

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Next-Generation Phenotypic Screening in Early Drug Discovery for Infectious Diseases

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Phasercrystallographic software

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

CCP4i2: the new graphical user interface to the CCP4 program suite.

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Features and development of Coot

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Towards automated crystallographic structure refinement with phenix.refine

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution.

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Free energy landscape for the binding process of Huperzine A to acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

SHAFTS: a hybrid approach for 3D molecular similarity calculation. 1. Method and assessment of virtual screening

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

MM-GB/SA rescoring of docking poses in structure-based lead optimization.

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

1 reference

https://api.crossref.org/works/10.1038/S41586-020-2223-Y

25 July 2020

Development of Ebselen, a Glutathione Peroxidase Mimic, for the Prevention and Treatment of Noise-Induced Hearing Loss

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2223-Y

7 January 2021

based on heuristic

inferred from DOI database lookup

xia2: an expert system for macromolecular crystallography data reduction

1 reference

https://api.crossref.org/works/10.1038%2FS41586-020-2223-Y

7 January 2021

based on heuristic

inferred from DOI database lookup

Design of wide-spectrum inhibitors targeting coronavirus main proteases

1 reference

https://pubmed.ncbi.nlm.nih.gov/32272481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A safe lithium mimetic for bipolar disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/32272481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design

1 reference

https://pubmed.ncbi.nlm.nih.gov/32272481

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/S41586-020-2223-Y

0 references

0 references

Dimensions Publication ID

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q89975279&oldid=1645898539"